LEI 969500R2W53JWRNZ2J74
ERVIMMUNE
Contract awards & public grants
Development of a cell immunotherapy targeting non-conventional tumor antigens in ovarian cancer → ERVIMMUNE
European Commission · FR · Grant · 2024-02-06
€2.5M
ERVIMMUNE — TEC-Breast
ANR · FR · Grant · 2022-01-01
€225,528
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.